Rapid detection of blood and semen mRNA markers by reverse transcription-recombinase polymerase amplification
Rapid detection of blood and semen mRNA markers by reverse transcription-recombinase polymerase amplification
复制标题
通过逆转录重组酶聚合酶扩增快速检测血液和精液 mRNA 标记
DOI:
10.1016/j.fsigen.2022.102665
复制
发表时间:
2022
期刊:
影响因子:
--
通讯作者:
Kitajima Isao
中科院分区:
文献类型:
--
作者:
Kubo Seiji;Niimi Hideki;Kitajima Isao
Body fluid identification is crucial for crime scene reconstruction. Recently, messenger RNA (mRNA) profiling has been an effective approach for body fluid identification. In general, mRNA is detected by real-time quantitative reverse transcription polymerase chain reaction (RT-qPCR) or end-point RT-PCR; however, these conventional methods are time-consuming and require extensive sample processing. Therefore, we developed a rapid and simple method for the detection of blood and semen mRNA markers by reverse transcription-recombinase polymerase amplification (RT-RPA). First, we screened mRNA markers for blood and semen and selected hemoglobin beta (HBB) and protamine 1 (PRM1), respectively, based on amplification specificity. Under optimized conditions, our RT-RPA assay detectedHBBandPRM1mRNAs within 20 min at a constant temperature of 42 °C. The detection limits for the assay were 0.01 ng/µL leukocyte RNA forHBBand 0.2 ng/µL semen RNA forPRM1. In addition, our RT-RPA assay exhibited high specificity and accuracy forHBBandPRM1mRNA detection from mixed samples. Furthermore, as RPA has been reported to possess inhibitor tolerance, we evaluated the feasibility of direct RT-RPA forHBBmRNA detection. This direct approach reduced the number of processing steps and time required for template preparation and enabled the successful detection ofHBBmRNA within 45 min from sample preparation. These findings suggest that RT-RPA is a useful method for mRNA-based blood and semen identification.